McColl has scientific qualifications, but he's not been a scientist for 20 odd years.
Prior to joining Viralytics in 2013, he was Vice President Business Development at Starpharma, where he led partnering activities and programs. From 2007 to 2010, he served as Director of Business Development for global healthcare company, Hospira (formerly Mayne Pharma and acquired by Pfizer in 2015), where he was responsible for Europe, The Middle East and Africa. In this UK-based position, he led negotiations for licensing and acquisition transactions primarily in the oncology field. Previously, he was Hospira’s Director of Business Development for the Asia/Pacific region, completing multiple partnering transactions and contributing to strong revenue growth in the region.
Dr. McColl also spent 13 years at CSL, a global specialty biotherapeutics company, culminating in his US-based role as Global Vice President, Business Development for the Animal Health Division. In this position, he played a lead role in the strategic development and globalisation of the Animal Health business, including entry into the US market.
Check out his LinkedIn profile.
VLA Price at posting:
72.5¢ Sentiment: Buy Disclosure: Held
